ThursdayAug 04, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances Drug Candidate to Fight Aggressive Brain Cancer Amid Difficult Era for Market

CNS Pharmaceuticals is a U.S.-based drug innovator developing novel chemotherapy agents capable of taking the fight against cancerous tumors across the blood-brain barrier to directly attack cancerous growths of the central nervous system  The company’s lead candidate is an anthracycline named Berubicin, which has previously shown promise among glioblastoma (“GBM”) patients in a safety study — particularly for one who remains cancer-free more than 15 years later CNS is enrolling patients in the United States, Italy, France, Spain, and Switzerland, for the global Phase 2 clinical trial to measure Berubicin’s potential to match or exceed the effectiveness of Lomustine, a…

Continue Reading

WednesdayAug 03, 2022 3:33 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Records First $9M Quarter

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced it recorded record revenues exceeding $9 million in the third fiscal quarter ended July 31, 2022. According to the update, this represents an estimated 177% improvement on revenues of $3.25 million in the comparable year-ago quarter. “We are excited by meaningful progress and growth in both our B2B and B2C divisions,” said Golden Matrix CEO Brian Goodman. “The company has now recorded its first $9 million quarter, which is even more impressive when considering the impact of global economic headwinds and an…

Continue Reading

WednesdayAug 03, 2022 2:34 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

Continue Reading

WednesdayAug 03, 2022 2:19 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Continues to Make Strides in Clean Tech Market

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) recently held its annual general meeting in which all seven of its board members were re-elected, with a new Chair, David Farrell. “Hillcrest also announced the completion of its transition toward clean energy technologies by formally announcing the end of its oilfield activities,” reads a recent article. “Hillcrest continues to make strides in its new clean tech market, where it concentrates on offering a flexible, single-inverter architecture applicable at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of electric vehicles to providing full-cycle efficiency and…

Continue Reading

WednesdayAug 03, 2022 2:00 pm

QualityStocksNewsBreaks – Why DPCM Capital Inc. (NYSE: XPOA) Is ‘One to Watch’

DPCM Capital (NYSE: XPOA), a special purpose acquisition company, is set to be part of a newly formed company, D-Wave Quantum Inc., following the expected closing of a transaction contained in a definitive agreement between itself and D-Wave Systems Inc., a leader in quantum computing systems, software and services. D-Wave is “focused on delivering customer value via practical applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection, and financial modeling,” a recent article reads. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization…

Continue Reading

WednesdayAug 03, 2022 1:51 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces Significant Expansion of Service to PG&E, Utility Company Doubles Number of ASRs under Contract

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to expand its footprint as new clients sign up for the K5 Autonomous Security Robots (“ASRs”) and existing clients add to their contracts. The most recently announced growth comes as the Pacific Gas and Electric Company (“PG&E”), the leading subsidiary of the holding company PG&E Corporation (NYSE: PCG), has ordered an additional five ASRs. PG&E has now contracted with Knightscope for 10 robots, which provide the levels of safety and overwatch necessary to secure the client’s properties. According to the announcement, PG&E first…

Continue Reading

WednesdayAug 03, 2022 1:30 pm

QualityStocksNewsBreaks – Iconic Brands Inc. (ICNB) Achieves Record Revenues in Q1 2022

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today released its financial results for the first quarter ended March 31, 2022. Among the highlights, the company reported $4,046,797 in total revenue for the first quarter, representing an increase of 538%, as well as $1,841,758 in gross profit, an increase of approximately 483% year over year. “The first quarter of 2022 was a testament to the strength of our business. We had record revenue for FY 2021 at $4.9 million, and this year we were able to achieve nearly that in just…

Continue Reading

WednesdayAug 03, 2022 12:00 pm

Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint Results, Suggests Topical Formulation Reduces Neuropathic Nerve Pain

Silo recently completed ketamine study showing neuropathic nerve pain reduction when administered with patented, partnered delivery system Results of study demonstrated Silo’s topical ketamine formulation reduced mechanical allodynia and hyperalgesia at both the pre-and post-dosing time points, mechanical hyperalgesia reduced on day seven at the pre-dose time point Ketamine typically used to induce and maintain anesthesia, drug use expanding to include depression and chronic pain treatment at subanesthetic doses Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company, recently completed a study of its ketamine formulation, showing nerve pain reduction when administered using a patented delivery system developed in partnership…

Continue Reading

WednesdayAug 03, 2022 11:15 am

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Strengthening Position with Acquisition of Large Rare Earth Deposit in Brazil

UUUU aggressively seeking to expand rare earth bearing monazite sand feeds Bahia Project offers potential to provide Energy Fuels with controlled, low-cost source of monazite Company plans extensive exploration work over the next several months to further define, quantify HMS and monazite resource at the Bahia Project As an emerging player in the commercial rare earth business, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has is strengthening its presence by entering into binding agreements to acquire 17 mineral concessions in Brazil (https://ibn.fm/o7vX5). The acquisitions, located in the state of Bahia and total approximately 58 square miles, have the potential to…

Continue Reading

WednesdayAug 03, 2022 10:30 am

As Other Competitors Enter the Music Streaming Market, Friendable Inc. (FDBL) and Fan Pass Live Continue Supporting Artists, Not Controlling Them

The global music streaming market is expected to reach $103.07 billion by 2030 – driven by platforms like Spotify TikTok’s parent company ByteDance has filed a trademark patent application for streaming services under the name “TikTok Music” Friendable’s Fan Pass Live artist streaming platform remains the only 360-degree offering that helps artists produce, distribute, and market music, while allowing artists to collect revenue and maintain complete control over their works With music streaming platforms rising in popularity, the global music streaming market is continuing to expand, being expected to reach $103.07 billion by 2030, growing at a CAGR of 14.7%…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered